sglt2 vs glp 1 Renal outcomes of inhibitors and GLP1 agonists in clinical practice SGLT2 inhibitors or GLP-1 receptor
Description
Vincenza Cifferelli, and Dr
This contributes to improved postprandial (after-meal) glucose control
Medicare is forbidden to cover any type of weight loss drug, although proposed legislation could change that
At the tissue level, GLP-1 agonists diminish ectopic fat accumulation in the liver and muscle, enhancing insulin sensitivity
Since GLP-1 RAs are primarily glucose-lowering medications, the benefits of selecting these agents should be weighed against the benefits of alternative diabetes control options
